Global and United States Pharmacovigilance (PV) Market 2020 by Company, Type and Application, Forecast to 2025

  • Market Overview

    The global Pharmacovigilance (PV) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 10.2% in the forecast period of 2020 to 2025 and will expected to reach USD 8412.7 million by 2025, from USD 5708 million in 2019.


    The Pharmacovigilance (PV) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.



    Market segmentation

    Pharmacovigilance (PV) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for revenue by Type and Application. This analysis can help you expand your business by targeting qualified niche markets.


    Breakdown by Type, Pharmacovigilance (PV) market has been segmented into Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining, etc.


    Breakdown by Application, Pharmacovigilance (PV) has been segmented into Hospitals, Research Organizations, Industrial, etc.




    Regions and Countries Level Analysis

    Regional analysis is another highly comprehensive part of the research and analysis study of the global Pharmacovigilance (PV) market presented in the report. This section sheds light on the sales growth of different regional and country-level Pharmacovigilance (PV) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Pharmacovigilance (PV) market.


    For United States, this report analyses the United States market by players, Type and Application, for the period 2015-2025.


    Competitive Landscape and Pharmacovigilance (PV) Market Share Analysis

    Pharmacovigilance (PV) competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Pharmacovigilance (PV) revenue generated, market share, headquarters, SWOT analysis, product launch. For the period 2015-2020, this study provides the Pharmacovigilance (PV) revenue and market share for each player covered in this report.


    The major players covered in Pharmacovigilance (PV) are: Accenture, Capgemini, Laboratory Corporation of America Holdings, Clinquest Group B.V., ICON plc., Cognizant, iMEDGlobal, ArisGlobal, IBM Corporation, ITClinical, Wipro Ltd., Foresight Group International AG, United BioSource Corporation, BioClinica, TAKE Solutions Ltd., PAREXEL International Corporation, etc. Among other players domestic and global, Pharmacovigilance (PV) market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.


    Market segment by players, this report covers

    Accenture

    Capgemini

    Laboratory Corporation of America Holdings

    Clinquest Group B.V.

    ICON plc.

    Cognizant

    iMEDGlobal

    ArisGlobal

    IBM Corporation

    ITClinical

    Wipro Ltd.

    Foresight Group International AG

    United BioSource Corporation

    BioClinica

    TAKE Solutions Ltd.

    PAREXEL International Corporation


    Market segment by regions, regional analysis covers

    North America (United States, Canada and Mexico)

    Europe (Germany, France, UK, Russia and Italy)

    Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)

    South America (Brazil, Argentina)

    MENA (Saudi Arabia, UAE, Turkey and South Africa)



    Market segment by Type, covers:

    Spontaneous Reporting

    Intensified ADR Reporting

    Targeted Spontaneous Reporting

    Cohort Event Monitoring

    EHR Mining



    Market segment by Application, can be divided into

    Hospitals

    Research Organizations

    Industrial

     

  • With tables and figures helping analyze worldwide Global and United States Pharmacovigilance (PV) market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.


    1 Market Overview

    1.1 Product Overview and Scope of Pharmacovigilance (PV)

    1.2 Classification of Pharmacovigilance (PV) by Type

    1.2.1 Overview: Global Pharmacovigilance (PV) Revenue by Type: 2015 Versus 2019 Versus 2025
    1.2.2 Global Pharmacovigilance (PV) Revenue Market Share by Type in 2019
    1.2.3 Spontaneous Reporting
    1.2.4 Intensified ADR Reporting
    1.2.5 Targeted Spontaneous Reporting
    1.2.6 Cohort Event Monitoring
    1.2.7 EHR Mining

    1.3 Global Pharmacovigilance (PV) Market by Application

    1.3.1 Overview: Global Pharmacovigilance (PV) Revenue by Application: 2015 Versus 2019 Versus 2025
    1.3.2 Hospitals
    1.3.3 Research Organizations
    1.3.4 Industrial

    1.4 Global Pharmacovigilance (PV) Market Size and Forecast (2015-2025)

    1.5 Global Pharmacovigilance (PV) Market Size by Regions: 2015 VS 2019 VS 2025

    1.6 Global Pharmacovigilance (PV) Market Size by Regions (2015-2020)

    1.7 Global Pharmacovigilance (PV) Market Size and Forecast by Regions (2020-2025)
    1.7.1 North America Pharmacovigilance (PV) Status and Prospect (2015-2025)
    1.7.2 Europe Pharmacovigilance (PV) Status and Prospect (2015-2025)
    1.7.3 Asia Pharmacovigilance (PV) Status and Prospect (2015-2025)
    1.7.4 South America Pharmacovigilance (PV) Status and Prospect (2015-2025)
    1.7.5 Middle East & Africa Pharmacovigilance (PV) Status and Prospect (2015-2025)

    2 Company Profiles

    2.1 Accenture

    2.1.1 Accenture Details
    2.1.2 Accenture Major Business and Total Revenue (Financial Highlights) Analysis
    2.1.3 Accenture SWOT Analysis
    2.1.4 Accenture Product and Services
    2.1.5 Accenture Pharmacovigilance (PV) Revenue, Gross Margin and Market Share (2018-2019)

    2.2 Capgemini

    2.2.1 Capgemini Details
    2.2.2 Capgemini Major Business and Total Revenue (Financial Highlights) Analysis
    2.2.3 Capgemini SWOT Analysis
    2.2.4 Capgemini Product and Services
    2.2.5 Capgemini Pharmacovigilance (PV) Revenue, Gross Margin and Market Share (2018-2019)

    2.3 Laboratory Corporation of America Holdings

    2.3.1 Laboratory Corporation of America Holdings Details
    2.3.2 Laboratory Corporation of America Holdings Major Business and Total Revenue (Financial Highlights) Analysis
    2.3.3 Laboratory Corporation of America Holdings SWOT Analysis
    2.3.4 Laboratory Corporation of America Holdings Product and Services
    2.3.5 Laboratory Corporation of America Holdings Pharmacovigilance (PV) Revenue, Gross Margin and Market Share (2018-2019)

    2.4 Clinquest Group B.V.

    2.4.1 Clinquest Group B.V. Details
    2.4.2 Clinquest Group B.V. Major Business and Total Revenue (Financial Highlights) Analysis
    2.4.3 Clinquest Group B.V. SWOT Analysis
    2.4.4 Clinquest Group B.V. Product and Services
    2.4.5 Clinquest Group B.V. Pharmacovigilance (PV) Revenue, Gross Margin and Market Share (2018-2019)

    2.5 ICON plc.

    2.5.1 ICON plc. Details
    2.5.2 ICON plc. Major Business and Total Revenue (Financial Highlights) Analysis
    2.5.3 ICON plc. SWOT Analysis
    2.5.4 ICON plc. Product and Services
    2.5.5 ICON plc. Pharmacovigilance (PV) Revenue, Gross Margin and Market Share (2018-2019)

    2.6 Cognizant

    2.6.1 Cognizant Details
    2.6.2 Cognizant Major Business and Total Revenue (Financial Highlights) Analysis
    2.6.3 Cognizant SWOT Analysis
    2.6.4 Cognizant Product and Services
    2.6.5 Cognizant Pharmacovigilance (PV) Revenue, Gross Margin and Market Share (2018-2019)
    2.7 iMEDGlobal
    2.7.1 iMEDGlobal Details
    2.7.2 iMEDGlobal Major Business and Total Revenue (Financial Highlights) Analysis
    2.7.3 iMEDGlobal SWOT Analysis
    2.7.4 iMEDGlobal Product and Services
    2.7.5 iMEDGlobal Pharmacovigilance (PV) Revenue, Gross Margin and Market Share (2018-2019)
    2.8 ArisGlobal
    2.8.1 ArisGlobal Details
    2.8.2 ArisGlobal Major Business and Total Revenue (Financial Highlights) Analysis
    2.8.3 ArisGlobal SWOT Analysis
    2.8.4 ArisGlobal Product and Services
    2.8.5 ArisGlobal Pharmacovigilance (PV) Revenue, Gross Margin and Market Share (2018-2019)
    2.9 IBM Corporation
    2.9.1 IBM Corporation Details
    2.9.2 IBM Corporation Major Business and Total Revenue (Financial Highlights) Analysis
    2.9.3 IBM Corporation SWOT Analysis
    2.9.4 IBM Corporation Product and Services
    2.9.5 IBM Corporation Pharmacovigilance (PV) Revenue, Gross Margin and Market Share (2018-2019)

    2.10 ITClinical

    2.10.1 ITClinical Details
    2.10.2 ITClinical Major Business and Total Revenue (Financial Highlights) Analysis
    2.10.3 ITClinical SWOT Analysis
    2.10.4 ITClinical Product and Services
    2.10.5 ITClinical Pharmacovigilance (PV) Revenue, Gross Margin and Market Share (2018-2019)
    2.11 Wipro Ltd.
    2.11.1 Wipro Ltd. Details
    2.11.2 Wipro Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
    2.11.3 Wipro Ltd. SWOT Analysis
    2.11.4 Wipro Ltd. Product and Services
    2.11.5 Wipro Ltd. Pharmacovigilance (PV) Revenue, Gross Margin and Market Share (2018-2019)
    2.12 Foresight Group International AG
    2.12.1 Foresight Group International AG Details
    2.12.2 Foresight Group International AG Major Business and Total Revenue (Financial Highlights) Analysis
    2.12.3 Foresight Group International AG SWOT Analysis
    2.12.4 Foresight Group International AG Product and Services
    2.12.5 Foresight Group International AG Pharmacovigilance (PV) Revenue, Gross Margin and Market Share (2018-2019)
    2.13 United BioSource Corporation
    2.13.1 United BioSource Corporation Details
    2.13.2 United BioSource Corporation Major Business and Total Revenue (Financial Highlights) Analysis
    2.13.3 United BioSource Corporation SWOT Analysis
    2.13.4 United BioSource Corporation Product and Services
    2.13.5 United BioSource Corporation Pharmacovigilance (PV) Revenue, Gross Margin and Market Share (2018-2019)
    2.14 BioClinica
    2.14.1 BioClinica Details
    2.14.2 BioClinica Major Business and Total Revenue (Financial Highlights) Analysis
    2.14.3 BioClinica SWOT Analysis
    2.14.4 BioClinica Product and Services
    2.14.5 BioClinica Pharmacovigilance (PV) Revenue, Gross Margin and Market Share (2018-2019)
    2.15 TAKE Solutions Ltd.
    2.15.1 TAKE Solutions Ltd. Details
    2.15.2 TAKE Solutions Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
    2.15.3 TAKE Solutions Ltd. SWOT Analysis
    2.15.4 TAKE Solutions Ltd. Product and Services
    2.15.5 TAKE Solutions Ltd. Pharmacovigilance (PV) Revenue, Gross Margin and Market Share (2018-2019)
    2.16 PAREXEL International Corporation
    2.16.1 PAREXEL International Corporation Details
    2.16.2 PAREXEL International Corporation Major Business and Total Revenue (Financial Highlights) Analysis
    2.16.3 PAREXEL International Corporation SWOT Analysis
    2.16.4 PAREXEL International Corporation Product and Services
    2.16.5 PAREXEL International Corporation Pharmacovigilance (PV) Revenue, Gross Margin and Market Share (2018-2019)

    3 Market Competition, by Players

    3.1 Global Pharmacovigilance (PV) Market Size by Players (2015-2020)

    3.2 United States Pharmacovigilance (PV) Market Size by Players (2015-2020)

    3.3 Market Concentration Rate

    3.3.1 Top 5 Pharmacovigilance (PV) Players Market Share
    3.3.2 Top 10 Pharmacovigilance (PV) Players Market Share

    4 North America Market Size and Forecast by Countries

    4.1 North America Pharmacovigilance (PV) Market Size by Countries (2015-2020)

    4.2 North America Pharmacovigilance (PV) Market Size and Forecast by Countries (2015-2026)

    4.3 United States Pharmacovigilance (PV) Market Size and Forecast (2015-2025)

    4.4 Canada Pharmacovigilance (PV) Market Size and Forecast (2015-2025)

    4.5 Mexico Pharmacovigilance (PV) Market Size and Forecast (2015-2025)


    5 Europe Market Size and Forecast by Countries

    5.1 Europe Pharmacovigilance (PV) Market Size by Countries (2015-2020)

    5.2 Europe Pharmacovigilance (PV) Market Size and Forecast by Countries (2015-2026)

    5.3 Germany Pharmacovigilance (PV) Market Size and Forecast (2015-2025)

    5.4 France Pharmacovigilance (PV) Market Size and Forecast (2015-2025)

    5.5 UK Pharmacovigilance (PV) Market Size and Forecast (2015-2025)

    5.6 Russia Pharmacovigilance (PV) Market Size and Forecast (2015-2025)

    5.7 Italy Pharmacovigilance (PV) Market Size and Forecast (2015-2025)

    6 Asia-Pacific Market Size and Forecast by Countries

    6.1 Asia-Pacific Pharmacovigilance (PV) Market Size by Regions (2015-2020)

    6.2 Asia-Pacific Pharmacovigilance (PV) Market Size and Forecast by Regions (2015-2026)

    6.3 China Pharmacovigilance (PV) Market Size and Forecast (2015-2025)

    6.4 Japan Pharmacovigilance (PV) Market Size and Forecast (2015-2025)

    6.5 Korea Pharmacovigilance (PV) Market Size and Forecast (2015-2025)

    6.6 India Pharmacovigilance (PV) Market Size and Forecast (2015-2025)

    6.7 Southeast Asia Pharmacovigilance (PV) Market Size and Forecast (2015-2025)

    7 South America Market Size and Forecast by Countries

    7.1 South America Pharmacovigilance (PV) Market Size by Countries (2015-2020)

    7.2 South America Pharmacovigilance (PV) Market Size and Forecast by Countries (2015-2026)

    7.3 Brazil Pharmacovigilance (PV) Market Size and Forecast (2015-2025)

    7.4 Argentina Pharmacovigilance (PV) Market Size and Forecast (2015-2025)


    8 Middle East & Africa Market Size and Forecast by Countries

    8.1 Middle East & Africa Pharmacovigilance (PV) Revenue by Regions (2015-2020)

    8.2 Middle East & Africa Pharmacovigilance (PV) Market Size and Forecast by Countries (2015-2026)

    8.3 Saudi Arabia Pharmacovigilance (PV) Market Size and Forecast (2015-2025)

    8.4 UAE Pharmacovigilance (PV) Market Size and Forecast (2015-2025)

    8.5 Egypt Pharmacovigilance (PV) Market Size and Forecast (2015-2025)

    8.6 South Africa Pharmacovigilance (PV) Market Size and Forecast (2015-2025)


    9 Market Size Segment by Type

    9.1 Global Pharmacovigilance (PV) Market Size and Forecast by Type (2015-2025)

    9.1.1 Global Pharmacovigilance (PV) Market Size by Type (2015-2020)
    9.1.2 Global Pharmacovigilance (PV) Market Size Forecast by Type (2020-2025)

    9.2 United States Pharmacovigilance (PV) Market Size and Forecast by Type (2015-2025)

    9.2.1 United States Pharmacovigilance (PV) Market Size by Type (2015-2020)
    9.2.2 United States Pharmacovigilance (PV) Market Size Forecast by Type (2020-2025)

    10 Market Size Segment by Application

    10.1 Global Pharmacovigilance (PV) Market Size and Forecast by Application (2015-2025)

    10.1.1 Global Pharmacovigilance (PV) Market Size by Application (2015-2020)
    10.1.2 Global Pharmacovigilance (PV) Market Size Forecast by Application (2020-2025)

    10.2 United States Pharmacovigilance (PV) Market Size and Forecast by Application (2015-2025)

    10.2.1 United States Pharmacovigilance (PV) Market Size by Application (2015-2020)
    10.2.2 United States Pharmacovigilance (PV) Market Size Forecast by Application (2020-2025)

    11 Research Findings and Conclusion

    12 Appendix

    12.1 Methodology

    12.2 Data Source

    12.3 Disclaimer

    12.4 About US

     

  • The Global and United States Pharmacovigilance (PV) Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.

    Report Objectives / Segmentation Covered :
    By Companies / players:
    • Accenture
    • Capgemini
    • Laboratory Corporation of America Holdings
    • Clinquest Group B.V.
    • ICON plc.
    • Cognizant
    • iMEDGlobal
    • ArisGlobal
    • IBM Corporation
    • ITClinical
    • Wipro Ltd.
    • Foresight Group International AG
    • United BioSource Corporation
    • BioClinica
    • TAKE Solutions Ltd.
    • PAREXEL International Corporation
    By Regions:
    • North America (United States, Canada and Mexico)
    • Europe (Germany, France, UK, Russia and Italy)
    • Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
    • South America (Brazil, Argentina)
    • MENA (Saudi Arabia, UAE, Turkey and South Africa)
    By Type:
      By Application:
      • Hospitals
      • Research Organizations
      • Industrial
    Licensing options
    3980
    USD

    Need assistance ?

    Research objectives

    Where will all these developments take the industry in the long

    To study and analyze the global Market consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.

    What are the future opportunities in the market?

    To understand the structure of Market by identifying its various subsegments.

    What are the major driving forces expected to impact the development of the market market across different regions?

    To analyze the market with respect to individual growth trends, future prospects, and their contribution to the total market.

    Which industry trends are likely to shape the future of the industry during the forecast period 2020-2025?

    To project the consumption of market submarkets, with respect to key regions.

    Who are the major driving forces expected to decide the fate of the industry worldwide.

    To strategically profile the key players and comprehensively analyze their growth strategies.

    What are the key barriers and threats believed to hinder the development of the industry?

    To analyze competitive developments such as expansions,agreements, new product launches, and acquisitions in the market.

    Who are the prominent market players making a mark in the market with their winning strategies?

    To share detailed information about the key factors influencing the growth of the market

    What will be the growth rate and the market size of the industry for the forecast period 2020-2025?

    Focuses on the key global market Vendors, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

    Our Clients